SCHEMBL19634864

SCHEMBL19634864

OC(O)c1ccnc(-c2cn(CC3CCCO3)cn2)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4C Q9H3R0 5/20 0.68
▸ KDM2B Q8NHM5 5/20 0.41
▸ WDR5 P61964 1/20 0.39
▸ KDM5B Q9UGL1 2/20 0.37
▸ KDM5A P29375 1/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ CYP1A2 P05177 2/20 0.37
▸ CYP2C9 P11712 2/20 0.37
▸ CYP2C19 P33261 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ PKM P14618 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ OPRM1 P35372 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ TSHR P16473 2/20 0.36
▸ USP2 O75604 1/20 0.34
▸ HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16032942 0.81 KDM4C (1.00) KDM4CKDM2BKDM5BKDM5A
SCHEMBL16034482 0.80 KDM4C (0.65) KDM4CKDM2BWDR5CYP1A2CYP2C9
SCHEMBL18612971 0.73 KDM4C (0.71) KDM4CKDM2BKDM5BKDM5APHF8
SCHEMBL18612958 0.69 KDM2B (0.69) KDM4CKDM2BKDM5BKDM5A
SCHEMBL24936211 0.69 KDM4C (0.48) KDM4CWDR5TDP1CYP1A2CYP2C9
Hydrochloric Acid SCHEMBL23389288 0.68 KDM4C (0.50) KDM4CWDR5TDP1CYP1A2CYP2C9
Hydrochloric Acid SCHEMBL23389291 0.68 KDM4C (0.50) KDM4CWDR5TDP1CYP1A2CYP2C9
SCHEMBL18612739 0.68 KDM4C (0.71) KDM4CKDM2BKDM5BKDM5A
SCHEMBL19139044 0.68 KDM2B (0.47) KDM4CKDM2BKDM5BKDM5A
SCHEMBL19101682 0.66 KDM5B (0.66) KDM4CKDM2BKDM5BKDM5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10273222-B2 Histone demethylase inhibitors CELGENE QUANTSCEL RESEARCH, INC. (US) 2019-04-30 — — US disclosed
US-20170334879-A1 HISTONE DEMETHYLASE INHIBITORS CELGENE QUANTICEL RES INC (US) 2017-11-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10273222-B2 Histone demethylase inhibitors KDM1B, KDM1A, KDM3B KDM4C 13/4885KDM2B 19/4885WDR5 955/4885
US-20170334879-A1 HISTONE DEMETHYLASE INHIBITORS KDM1B, KDM1A, KDM3B KDM4C 13/4885KDM2B 19/4885WDR5 955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback